The Trials – Phase 2

EBOVAC2 logo

Phase 2 trials are being carried out in Europe and Africa by the EBOVAC2 consortium. More information on Phase 2 is available on the EBOVAC2 website.

These projects have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement EBOVAC1 (grant nr. 115854), EBOVAC2 (grant nr. 115861), EBOMAN (grant nr. 115850) and EBODAC (grant nr. 115847). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations (EFPIA).
Copyright © 2019 Ebovac | Terms and Conditions | WordPress development by Toast.